Concerning the latter, contradicting results had been previously reported by Watanabe et al. [45], who suggested a low significance of LAT1 as a prognostic marker since its expression had been low in poorly differentiated adenocarcinomas and correlated with neither proliferative activity nor the International Federation of Gynecology and Obstetrics stage. This evidence concerns the gene SLC7A5 and adenocarcinoma.